| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, University of Toronto Toronto, Ontario, Canada
Department of Clinical Biochemistry, University of Toronto Toronto, Ontario, Canada
Department of Genetics, University of Toronto Toronto, Ontario, Canada
Department of Pathology, University of Toronto Toronto, Ontario, Canada
Address requests for reprints to: Daniel Drucker, M.D., Toronto General Hospital, 200 Elizabeth Street, CCRW3–838, Toronto, Ontario, Canada M5G 2C4.
Abstract
The phenotypically distinct cell types of the islets of Langerhans express a number of different hormone genes in a regulated and cell-specific manner. Analysis of the molecular factors important for the control of insulin gene transcription has led to the identification of a number of insulin gene-binding proteins. The cDNAs for several of these proteins have been isolated, including isl-1, a LIM domain homeobox protein reported to be preferentially expressed in islet cells. We now report that isl-1 mRNA transcripts are present not only in islet cells, but also in pheochromocytoma (PC-12) cell lines. Isl-1 mRNA transcripts were also detected in several different regions of rat brain as well as in rat kidney. Analysis of the patterns of gene expression in rate islet cell lines and human pancreatic endocrine tumors demonstrated a variable relationship between the hormonal phenotype of the tumor and expression of the isl-1 and insulin genes. Immunocytochemical studies demonstrated both cytoplasmic and nuclear staining for isl-1 in human pancreatic endocrine tumors, in normal pancreatic A, B, D, and PP cells, and in distal tubular cells of the kidney. Isl-1 immunoreactivity was also widely distributed in neurons in both the central and peripheral nervous system, pituitary, and several human pituitary tumors and pheochromocytomas. The results of these studies implicate a potential role for isl-1 outside the endocrine pancreas in the nervous system and kidney.
FOOTNOTES
This work was supported in part by grants from the Canadian Diabetes Association and the Medical Research Council of Canada.
* Career Scientist of the Ontario Ministry of Health.
Received for publication July 16, 1991. Revision received August 16, 1991. Accepted for publication August 20, 1991.
This article has been cited by other articles:
 |
|
 |
|
  C. Suzuki, H. Nagasaki, Y. Okajima, H. Suga, N. Ozaki, H. Arima, Y. Iwasaki, and Y. Oiso Inflammatory Cytokines Regulate Glycoprotein Subunit {beta}5 of Thyrostimulin through Nuclear Factor-{kappa}B Endocrinology, May 1, 2009; 150(5): 2237 - 2243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Jin Mechanisms underlying proglucagon gene expression J. Endocrinol., July 1, 2008; 198(1): 17 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhao, T. Liu, N. Zhang, F. Yi, Q. Wang, I. G. Fantus, and T. Jin Role of Cdx-2 in insulin and proglucagon gene expression: a study using the RIN-1056A cell line with an inducible gene expression system J. Endocrinol., July 1, 2005; 186(1): 179 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gay, I. Anglade, Z. Gong, and G. Salbert The LIM/Homeodomain Protein Islet-1 Modulates Estrogen Receptor Functions Mol. Endocrinol., October 1, 2000; 14(10): 1627 - 1648. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. W. Jurata, S. L. Pfaff, and G. N. Gill The Nuclear LIM Domain Interactor NLI Mediates Homo- and Heterodimerization of LIM Domain Transcription Factors J. Biol. Chem., February 6, 1998; 273(6): 3152 - 3157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wang and D. J. Drucker The LIM Domain Homeobox Gene isl-1 Is a Positive Regulator of Islet Cell-specific Proglucagon Gene Transcription J. Biol. Chem., May 26, 1995; 270(21): 12646 - 12652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gong, C.-c. Hui, and C. L. Hew Presence of isl-1-related LIM Domain Homeobox Genes in Teleost and Their Similar Patterns of Expression in Brain and Spinal Cord J. Biol. Chem., February 17, 1995; 270(7): 3335 - 3345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M S German, J Wang, R B Chadwick, and W J Rutter Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes & Dev., November 1, 1992; 6(11): 2165 - 2176. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
